Pages that link to "Q43003809"
Jump to navigation
Jump to search
The following pages link to The use of hyperimmune antivaccinia gamma-globulin for the prevention and treatment of smallpox (Q43003809):
Displaying 11 items.
- Wanted, dead or alive: New viral vaccines (Q27489979) (← links)
- Combination therapy of vaccinia virus infection with human anti-H3 and anti-B5 monoclonal antibodies in a small animal model (Q33967713) (← links)
- Antiviral immunity following smallpox virus infection: a case-control study (Q34416523) (← links)
- Therapeutic Vaccines and Antibodies for Treatment of Orthopoxvirus Infections (Q34447009) (← links)
- Protection of rabbits and immunodeficient mice against lethal poxvirus infections by human monoclonal antibodies (Q34469836) (← links)
- Redundancy and plasticity of neutralizing antibody responses are cornerstone attributes of the human immune response to the smallpox vaccine (Q36498147) (← links)
- Vaccinia virus extracellular enveloped virion neutralization in vitro and protection in vivo depend on complement (Q37051617) (← links)
- Heavily isotype-dependent protective activities of human antibodies against vaccinia virus extracellular virion antigen B5. (Q37452067) (← links)
- The smallpox vaccine induces an early neutralizing IgM response (Q37456873) (← links)
- Are We Prepared in Case of a Possible Smallpox-Like Disease Emergence? (Q47116100) (← links)
- TETRACYCLINES IN THE DOCK (Q76711745) (← links)